Supitchaya is a second-year PhD student in the Department of Pharmacology at Monash University as part of the IRAP Pharmacology Group and Cardiovascular and Pulmonary Pharmacology Group. Her area of research focuses on identifying novel therapeutic targets to treat Pulmonary Hypertension (PH). After completing her Honours at Monash, she worked as a research assistant at the Garvan Institute of Medical Research, testing compounds in preclinical mouse models of pancreatic cancer. Now, she continues her work in PH, investigating IRAP as a novel therapeutic target. This involves testing IRAP inhibitors and performing right heart catheterisation in mouse models of PH, and utilising immunohistochemistry to explore pathological changes within the lungs. She hopes to contribute to cardiovascular therapeutic testing and discover novel treatments to improve patient outcomes.